Michael Arnold Speaks at Council of Institutional Investors Webinar on the SEC’s Climate Disclosure Proposal

Cravath represented Vaxxinity, Inc. in connection with its initial public offering. Vaxxinity is a U.S.‑based global biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Shares began trading on November 11, 2021 on The Nasdaq Global Market.

Cravath represented IsoPlexis Corporation in connection with its $125 million initial public offering of common stock. IsoPlexis Corporation is a life sciences company building solutions to accelerate the development of curative medicines and personalized therapeutics. The shares were listed on The Nasdaq Global Select Market. The transaction closed on October 12, 2021.

On March 18, 2021, National Grid plc (“National Grid”) announced that it has agreed to acquire Western Power Distribution, the UK’s largest electricity distribution business, from PPL Corporation (“PPL”) for an equity value of £7.8 billion, and that National Grid has agreed to sell The Narragansett Electric Company, Rhode Island’s largest electricity transmission and distribution service provider, to PPL for an equity value of $3.8 billion. Cravath is representing National Grid in connection with the transactions.

On November 10, 2020, Ulta Beauty, the largest U.S. beauty retailer, and Target Corporation announced a strategic, long‑term partnership to transform the beauty landscape with Ulta Beauty at Target. The “shop‑in‑shop” concept will offer established and emerging prestige brands online and debut at more than 100 Target locations nationwide starting in 2021, with plans to scale to hundreds more over time. Cravath is representing Ulta Beauty with assistance on certain matters from Foley & Lardner LLP in connection with the partnership.